Population pharmacokinetic analysis of infliximab in patients with ulcerative colitisAdedigbo A. Fasanmade, Honghui Zhou, Omoniyi J. Adedokun et al.|European Journal of Clinical Pharmacology|2009Cited by 322
Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative ColitisOmoniyi J. Adedokun, Jeffrey S. Hyams, Lakshmi Padgett et al.|Inflammatory Bowel Diseases|2013Cited by 83
Sa1203 Pharmacokinetics and Exposure-Response Relationship of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase2/3 Induction and Maintenance StudiesOmoniyi J. Adedokun, William J. Sandborn, Zhenhua Xu et al.|Gastroenterology|2013Cited by 4
Sa1989 Pharmacokinetics of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis: Results From a Randomized, Multicenter, Open-Label Phase 3 StudyOmoniyi J. Adedokun, Jeffrey S. Hyams, Zhenhua Xu et al.|Gastroenterology|2012Cited by 0